Rafael Mendez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rafael Mendez has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Adriana Posada
Pontificia Universidad Javeriana
1 shared publication- Alejandra De-La-Torre
Universidad del Rosario
1 shared publication - Ariel Schlaen
Department of Ophthalmology, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina
1 shared publication - Camilo Eduardo Martínez-Sanchez
Department of Ophthalmology Pontificia Universidad Javeriana Bogotá Colombia
1 shared publication - Carlos Cifuentes-González
National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore
1 shared publication Cristobal Couto
Uveitis Section, Ophthalmology Department, Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
1 shared publication
Latest Publications
- 18 November 2025
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 248-251
Acute angle closure as an atypical presentation of ocular cysticercosis, a case report
Ocular cysticercosis is an endemic disease in developing countries with diverse clinical presentations depending on the cyst location. We highlight a case of subretinal intraocular cysticercosis that presented with acute angle closure, an atypical clinical presentation. The initial treatment involved medical therapy with albendazole, oral steroids, and ocular hypotensive agents. During follow-up, despite symptom control and ocular hypertension, a significant intraocular inflammatory reaction was identified, requiring surgical management. The patient underwent pars plana vitrectomy with favorable anatomical and visual outcomes. This case emphasizes the importance of recognizing atypical clinical presentations to promote timely diagnosis and treatment and suggests that cyst size may influence the inflammatory response and the decision between medical or surgical management.
- 18 November 2025
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 248-251
Acute angle closure as an atypical presentation of ocular cysticercosis, a case report
Ocular cysticercosis is an endemic disease in developing countries with diverse clinical presentations depending on the cyst location. We highlight a case of subretinal intraocular cysticercosis that presented with acute angle closure, an atypical clinical presentation. The initial treatment involved medical therapy with albendazole, oral steroids, and ocular hypotensive agents. During follow-up, despite symptom control and ocular hypertension, a significant intraocular inflammatory reaction was identified, requiring surgical management. The patient underwent pars plana vitrectomy with favorable anatomical and visual outcomes. This case emphasizes the importance of recognizing atypical clinical presentations to promote timely diagnosis and treatment and suggests that cyst size may influence the inflammatory response and the decision between medical or surgical management.
- 10 January 2024
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (8) , 1882-1887
Ibrutinib-Related Uveitis in Non-Hodgkin Lymphoma Patients: A Case Report and Literature Review
PurposeTo report two cases of ibrutinib-related uveitis and review the literature to date.MethodsWe report two cases of ibrutinib-related uveitis using CARE guidelines and review the cases reported in the literature.ResultsCase 1) A 55-year-old female with recurrent primary central nervous system lymphoma presented with bilateral decreased visual acuity, photophobia, and floaters that started one month after initiating oral treatment with ibrutinib. Chronic non-granulomatous bilateral anterior-intermediate uveitis with macular edema was identified. Secondary causes were ruled out, and a presumptive diagnosis of ibrutinib-related uveitis was made. Case 2) A 57-year-old female with Waldenstrom macroglobulinemia who was treated with ibrutinib for two years presented with bilateral blurred vision, photophobia, red eyes, and floaters. A diagnosis of non-granulomatous, noninfectious panuveitis with bilateral cystoid macular edema was made. Secondary causes were ruled out, and ibrutinib toxicity was the most likely cause.ConclusionIbrutinib-related uveitis is a novel and under-diagnosed clinical entity. The most frequent clinical presentation in the literature is bilateral, non-granulomatous, anterior, and intermediate uveitis. Macular edema is a frequent complication. Uveitis usually requires topical treatment and the suspension of ibrutinib. Switching to second-generation Bruton tyrosine kinase inhibitors is proposed as a potential therapeutic alternative.
- 10 January 2024
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (8) , 1882-1887
Ibrutinib-Related Uveitis in Non-Hodgkin Lymphoma Patients: A Case Report and Literature Review
PurposeTo report two cases of ibrutinib-related uveitis and review the literature to date.MethodsWe report two cases of ibrutinib-related uveitis using CARE guidelines and review the cases reported in the literature.ResultsCase 1) A 55-year-old female with recurrent primary central nervous system lymphoma presented with bilateral decreased visual acuity, photophobia, and floaters that started one month after initiating oral treatment with ibrutinib. Chronic non-granulomatous bilateral anterior-intermediate uveitis with macular edema was identified. Secondary causes were ruled out, and a presumptive diagnosis of ibrutinib-related uveitis was made. Case 2) A 57-year-old female with Waldenstrom macroglobulinemia who was treated with ibrutinib for two years presented with bilateral blurred vision, photophobia, red eyes, and floaters. A diagnosis of non-granulomatous, noninfectious panuveitis with bilateral cystoid macular edema was made. Secondary causes were ruled out, and ibrutinib toxicity was the most likely cause.ConclusionIbrutinib-related uveitis is a novel and under-diagnosed clinical entity. The most frequent clinical presentation in the literature is bilateral, non-granulomatous, anterior, and intermediate uveitis. Macular edema is a frequent complication. Uveitis usually requires topical treatment and the suspension of ibrutinib. Switching to second-generation Bruton tyrosine kinase inhibitors is proposed as a potential therapeutic alternative.
- Open Access
- 9 September 2019
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- Vol. 23 (4) , 347-351
Características clínicas y microbiológicas de pacientes con neutropenia febril en un hospital universitario
Objetivo: Describir las características clínicas, demográficas, frecuencia, tipo de aislamientos microbiológicos y resistencia a los antimicrobianos de pacientes con neoplasias hematológicas que presentaron como complicación neutropenia febril en el Hospital Universitario de San IgnacioMétodos: Estudio descriptivo observacional, se tomaron datos de historias clínicas de los pacientes adultos hospitalizados en la Unidad de Hematología y Trasplante de Médula Ósea, que cumplieron criterios de neutropenia febril entre enero de 2013 y diciembre de 2014Resultados: se recolectaron 345 episodios de neutropenia febril, correspondientes a 193 pacientes. Se documentó foco infeccioso en el 68,1% de los episodios, con aislamiento microbiológico en el 62.9% de los episodios, con predominio de bacilos gram negativos, en 63,7% de los casos, seguido por los cocos gram positivos en 27,9% y hongos en 4,9%. En cuanto a los mecanismos de resistencia, en los aislamientos Escherichia coli y Klebsiella peumoniae se encontró producción de Beta Lactamasas de Espectro Extendido (BLEEs) en 17,5 y 13,8%; Carbapenemasas tipo KPC en 1,25 y 2,8% respectivamente. En cuanto a Staphylococcus aureus, se encontró resistencia a meticilina en 6,8% de los aislamientos. Mortalidad asociada a infección en 16,5% de los casos.Conclusión: En pacientes con Neoplasias Hematológicas con neutropenia febril post quimioterapia en el Hospital Universitario de San Ignacio encontramos alta probabilidad de documentación de foco infeccioso, con predominio de microorganismos gram negativos, especialmente enterobacterias; con comportamiento similar en pacientes post trasplante de precursores hematopoyéticos.
- 9 September 2019
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- Vol. 23 (4) , 347-351
Open AccessCaracterísticas clínicas y microbiológicas de pacientes con neutropenia febril en un hospital universitario
Objetivo: Describir las características clínicas, demográficas, frecuencia, tipo de aislamientos microbiológicos y resistencia a los antimicrobianos de pacientes con neoplasias hematológicas que presentaron como complicación neutropenia febril en el Hospital Universitario de San IgnacioMétodos: Estudio descriptivo observacional, se tomaron datos de historias clínicas de los pacientes adultos hospitalizados en la Unidad de Hematología y Trasplante de Médula Ósea, que cumplieron criterios de neutropenia febril entre enero de 2013 y diciembre de 2014Resultados: se recolectaron 345 episodios de neutropenia febril, correspondientes a 193 pacientes. Se documentó foco infeccioso en el 68,1% de los episodios, con aislamiento microbiológico en el 62.9% de los episodios, con predominio de bacilos gram negativos, en 63,7% de los casos, seguido por los cocos gram positivos en 27,9% y hongos en 4,9%. En cuanto a los mecanismos de resistencia, en los aislamientos Escherichia coli y Klebsiella peumoniae se encontró producción de Beta Lactamasas de Espectro Extendido (BLEEs) en 17,5 y 13,8%; Carbapenemasas tipo KPC en 1,25 y 2,8% respectivamente. En cuanto a Staphylococcus aureus, se encontró resistencia a meticilina en 6,8% de los aislamientos. Mortalidad asociada a infección en 16,5% de los casos.Conclusión: En pacientes con Neoplasias Hematológicas con neutropenia febril post quimioterapia en el Hospital Universitario de San Ignacio encontramos alta probabilidad de documentación de foco infeccioso, con predominio de microorganismos gram negativos, especialmente enterobacterias; con comportamiento similar en pacientes post trasplante de precursores hematopoyéticos.